Download PDF: Pathophysiology of ED Vasculogenic Cardiovascular disease – Hypertension – Diabetes mellitus – Hyperlipidaemia – Smoking – Major surgery (RP) or radiotherapy (pelvis or retroperitoneum) Neurogenic Central causes – Degenerative disorders (multiple sclerosis, Parkinson’s disease, multiple atrophy etc.) – Spinal cord trauma or diseases – Stroke – Central nervous system tumours Peripheral causes – […]
Diagnostic Evaluation of Erectile Dysfunction
July 1, 2014 by Leave a Comment
Download PDF: Minimal Diagnostic Evaluation of ED See also: Pathophysiology of Erectile Dysfunction Treatment Algorithm for Erectile Dysfunction Reference: Wespes E et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology. Update March 2013. Available at: http://www.uroweb.org/gls/pdf/14_Male%20Sexual%20Dysfunction_LR.pdf
Treatment Algorithm for Erectile Dysfunction
July 1, 2014 by Leave a Comment
Download PDF: Treatment Algorithm for ED See also: Pathophysiology of Erectile Dysfunction Diagnostic Evaluation in Patients with Erectile Dysfunction Reference: Wespes E et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology. Update March 2013. Available at: http://www.uroweb.org/gls/pdf/14_Male%20Sexual%20Dysfunction_LR.pdf
Brupro for Children
July 1, 2014 by Leave a Comment
Company: Rowex Ltd. Legal category: OTC. Sport permitted. Active ingredient: Ibuprofen 100mg/5ml. Description: Oral suspension. Presentation: 100ml, €3.50; 150ml, €5.00. Indications: Short-term treatment of mild to moderate pain, fever in children from 5kg (3 months) to 39kg (11 years). Pharmacology: Ibuprofen is a non-steroidal anti-inflammatory drug that is effective via prostaglandin-synthesis inhibition. It has an […]
Orencia Injection
July 1, 2014 by Leave a Comment
Company: Bristol‑Myers Squibb Pharmaceuticals. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Abatacept 125mg/ml. Description: Solution for injection in pre-filled syringe. Presentation: 1ml-4, €904.00. Indications: Use in combination with methotrexate for treatment of moderate to severe active rheumatoid arthritis in adults who have had an insufficient response to other disease‑modifying anti‑rheumatic drugs (DMARDs) including […]
Palexia Oral Solution
July 1, 2014 by Leave a Comment
Company: Grunenthal Pharma Ltd. Legal category: Controlled drug. GMS. Sport permitted. Active ingredient: Tapentadol (hydrochloride) 20mg/ml. Description: Oral solution. Presentation: 200ml, €42.00. Indications: Relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics. Pharmacology: Tapentadol is a strong analgesic with µ-agonistic opioid and additional noradrenaline reuptake inhibition […]
Perjeta ▼
July 1, 2014 by Leave a Comment
Company: Roche Products (Ireland) Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Pertuzumab 420mg per vial. Description: Concentrate for solution for infusion. Presentation: Price available on request. Indications: For use in combination with trastuzumab and docetaxel in adults with HER2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-HER2 therapy […]
Loading ...
